{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:24:40Z","timestamp":1790529880527,"version":"4.1.0"},"reference-count":94,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T00:00:00Z","timestamp":1517875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1093\/jac\/dkx539","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T04:19:32Z","timestamp":1514953172000},"page":"1247-1255","source":"Crossref","is-referenced-by-count":15,"title":["Meropenem potentiation of aminoglycoside activity against Pseudomonas aeruginosa: involvement of the MexXY-OprM multidrug efflux system"],"prefix":"10.1093","volume":"73","author":[{"given":"Keith","family":"Poole","sequence":"first","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Botterell Hall, Queen\u2019s University, Kingston, Ontario K7L 3N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie","family":"Gilmour","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Botterell Hall, Queen\u2019s University, Kingston, Ontario K7L 3N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya A","family":"Farha","sequence":"additional","affiliation":[{"name":"M.G. DeGroote Institute for Infectious Disease Research and Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Parkins","sequence":"additional","affiliation":[{"name":"Department of Microbiology Immunology and Infectious Diseases and Department of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Klinoski","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Molecular Sciences, Botterell Hall, Queen\u2019s University, Kingston, Ontario K7L 3N6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D","family":"Brown","sequence":"additional","affiliation":[{"name":"M.G. DeGroote Institute for Infectious Disease Research and Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario L8N 3Z5, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,6]]},"reference":[{"key":"key\n\t\t\t\t20180626060813_dkx539-B1","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1128\/AAC.00469-10","article-title":"Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008)","volume":"54","author":"Zhanel","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B2","article-title":"Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP\/CAP study","author":"Koulenti","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prrv.2010.07.003","article-title":"Challenging and emerging pathogens in cystic fibrosis","volume":"11","author":"de Vrankrijker","year":"2010","journal-title":"Paediatr Respir Rev"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B4","doi-asserted-by":"crossref","first-page":"614","DOI":"10.12968\/hmed.2011.72.11.614","article-title":"Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and new treatments","volume":"72","author":"Brugha","year":"2011","journal-title":"Br J Hosp Med (Lond)"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2217\/17460913.2.2.153","article-title":"Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection","volume":"2","author":"Govan","year":"2007","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B6","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijantimicag.2017.02.026","article-title":"Correlation between phenotypic antibiotic susceptibility and the resistome in Pseudomonas aeruginosa","volume":"50","author":"Jaillard","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1128\/AAC.03954-14","article-title":"The resistome of Pseudomonas aeruginosa in relationship to phenotypic susceptibility","volume":"59","author":"Kos","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B8","doi-asserted-by":"crossref","first-page":"5555","DOI":"10.1038\/s41598-017-05621-5","article-title":"Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone","volume":"7","author":"L\u00f3pez-Causap\u00e9","year":"2017","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1586\/14787210.2015.1064310","article-title":"Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review","volume":"13","author":"Buhl","year":"2015","journal-title":"Exp Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drup.2015.08.002","article-title":"The increasing threat of Pseudomonas aeruginosa high-risk clones","volume":"21-22","author":"Oliver","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B11","doi-asserted-by":"crossref","DOI":"10.1093\/jpids\/piw064","article-title":"Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in children, United States, 1999-2012","author":"Logan","year":"2016","journal-title":"J Pediatr Infect Dis Soc"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/mdr.2016.0048","article-title":"Increasing incidence of multidrug resistance among cystic fibrosis respiratory bacterial isolates","volume":"23","author":"Rutter","year":"2017","journal-title":"Microb Drug Resist"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijantimicag.2017.03.034","article-title":"Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study","volume":"50","author":"L\u00f3pez-Causap\u00e9","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B14","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ppul.22813","article-title":"Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V. Aminoglycosides","volume":"48","author":"Young","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B15","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QCO.0000000000000217","article-title":"Managing Pseudomonas aeruginosa respiratory infections in cystic fibrosis","volume":"28","author":"Langan","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1753465817691239","article-title":"Tobramycin inhalation powder for the treatment of pulmonary Pseudomonas aeruginosa infection in patients with cystic fibrosis: a review based on clinical evidence","volume":"11","author":"Hamed","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B17","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0897190014546836","article-title":"Aminoglycoside-induced nephrotoxicity","volume":"27","author":"Wargo","year":"2014","journal-title":"J Pharm Pract"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jcf.2013.03.005","article-title":"A review of renal disease in cystic fibrosis","volume":"12","author":"Nazareth","year":"2013","journal-title":"J Cyst Fibros"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B19","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00467-015-3097-3","article-title":"Risk factors for acute kidney injury during aminoglycoside therapy in patients with cystic fibrosis","volume":"30","author":"Downes","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/0897190014546102","article-title":"Aminoglycoside-induced nephrotoxicity\u2014a focus on monitoring: a review of literature","volume":"27","author":"Destache","year":"2014","journal-title":"J Pharm Pract"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2015","journal-title":"J Cyst Fibros"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/ppul.23763","article-title":"Prevalence of hearing and vestibular loss in cystic fibrosis patients exposed to aminoglycosides","volume":"52","author":"Handelsman","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B23","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/INF.0000000000000714","article-title":"Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade","volume":"34","author":"Raidt","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/emph\/eow016","article-title":"Association between clinical antibiotic resistance and susceptibility of Pseudomonas in the cystic fibrosis lung","volume":"2016","author":"Jansen","year":"2016","journal-title":"Evol Med Public Health"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/resp.12714","article-title":"Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres","volume":"21","author":"Smith","year":"2016","journal-title":"Respirology"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B26","first-page":"204","article-title":"Cultured human proximal tubule cells as a model for aminoglycoside nephrotoxicity","volume":"18","author":"Sens","year":"1988","journal-title":"Ann Clin Lab Sci"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3109\/00016488309132877","article-title":"Aspects on the ototoxic potential of netilmicin","volume":"96","author":"Anniko","year":"1983","journal-title":"Acta Otolaryngol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1128\/AAC.49.2.479-487.2005","article-title":"Aminoglycoside resistance in Pseudomonas aeruginosa","volume":"49","author":"Poole","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"2","author":"Poole","year":"2011","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B30","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1128\/AAC.43.12.2877","article-title":"Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis","volume":"43","author":"Shawar","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B31","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/AAC.00148-07","article-title":"Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation","volume":"51","author":"Henrichfreise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1469-0691.2008.02097.x","article-title":"Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"15","author":"Islam","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B33","doi-asserted-by":"crossref","first-page":"e0172179","DOI":"10.1371\/journal.pone.0172179","article-title":"Within-host whole genome analysis of an antibiotic resistant Pseudomonas aeruginosa strain sub-type in cystic fibrosis","volume":"12","author":"Sherrard","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/thoraxjnl-2015-208027","article-title":"Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene","volume":"72","author":"Prickett","year":"2017","journal-title":"Thorax"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1128\/AAC.48.5.1676-1680.2004","article-title":"Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis","volume":"48","author":"Vogne","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1128\/AAC.01252-13","article-title":"Multiple mutations lead to MexXY-OprM-dependent aminoglycoside resistance in clinical strains of Pseudomonas aeruginosa","volume":"58","author":"Gu\u00e9nard","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B37","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/JB.188.5.1847-1855.2006","article-title":"Antibiotic inducibility of the MexXY multidrug efflux system of Pseudomonas aeruginosa: involvement of the antibiotic-inducible PA5471 gene product","volume":"188","author":"Morita","year":"2006","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B38","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/AAC.45.6.1761-1770.2001","article-title":"Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa","volume":"45","author":"de Kievit","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B39","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/AAC.47.10.3202-3207.2003","article-title":"Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates","volume":"47","author":"Sobel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B40","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/j.1365-2958.2004.04210.x","article-title":"MexAB-OprM hyperexpression in NalC type multidrug resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719","volume":"53","author":"Cao","year":"2004","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B41","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1099\/00221287-146-8-2019","article-title":"Rapid detection of polyhydroxyalkanoate-accumulating bacteria isolated from the environment by colony PCR","volume":"146","author":"Sheu","year":"2000","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B42","volume-title":"Molecular Cloning: A Laboratory Manual","author":"Sambrook","year":"2001","edition":"3rd edn."},{"key":"key\n\t\t\t\t20180626060813_dkx539-B43","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1128\/AAC.03069-15","article-title":"Potentiation of aminoglycoside activity in Pseudomonas aeruginosa by targeting the AmgRS envelope stress-responsive two-component system","volume":"60","author":"Poole","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B44","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1128\/AAC.47.3.1101-1111.2003","article-title":"Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins","volume":"47","author":"Jo","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B45","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.1128\/AAC.00846-12","article-title":"Reduced expression of the rplU-rpmA ribosomal protein operon in mexXY-expressing pan-aminoglycoside-resistant Pseudomonas aeruginosa","volume":"56","author":"Lau","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B46","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1128\/AAC.00170-13","article-title":"Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa","volume":"57","author":"Lau","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/AAC.47.1.27-33.2003","article-title":"Contributions of MexAB-OprM and an EmrE homolog to intrinsic resistance of Pseudomonas aeruginosa to aminoglycosides and dyes","volume":"47","author":"Li","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B48","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1128\/AAC.00507-08","article-title":"Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa","volume":"52","author":"Schurek","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B49","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1128\/AAC.01446-12","article-title":"Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa","volume":"56","author":"Krahn","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B50","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1128\/AAC.43.11.2624","article-title":"Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides","volume":"43","author":"Aires","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B51","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/AAC.34.1.52","article-title":"Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa","volume":"34","author":"Trias","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B53","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1128\/AAC.44.9.2242-2246.2000","article-title":"Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B54","doi-asserted-by":"crossref","first-page":"14570","DOI":"10.1073\/pnas.0903619106","article-title":"Targeting a bacterial stress response to enhance antibiotic action","volume":"106","author":"Lee","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B55","doi-asserted-by":"crossref","first-page":"e00047","DOI":"10.1128\/mBio.00047-16","article-title":"Fine-tuning of the Cpx envelope stress response is required for cell wall homeostasis in Escherichia coli","volume":"7","author":"Delhaye","year":"2016","journal-title":"mBio"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B56","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/AAC.01529-07","article-title":"Affinity of doripenem and comparators to penicillin-binding proteins in Escherichia coli and Pseudomonas aeruginosa","volume":"52","author":"Davies","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/35.1.75","article-title":"Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by \u03b2-lactamases","volume":"35","author":"Yang","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B58","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1128\/AAC.39.9.1948","article-title":"Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa","volume":"39","author":"Li","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0002-9343(85)90185-8","article-title":"Combinations of antibiotics against Pseudomonas aeruginosa","volume":"79","author":"Baltch","year":"1985","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/jac\/10.3.227","article-title":"Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis","volume":"10","author":"Levy","year":"1982","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0732-8893(02)00420-0","article-title":"Cefepime, piperacillin\/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa","volume":"44","author":"Burgess","year":"2002","journal-title":"Diagn Microbiol Infec Dis"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0732-8893(00)00162-0","article-title":"Activity of piperacillin\/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill","volume":"38","author":"Burgess","year":"2000","journal-title":"Diagn Microbiol Infec Dis"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1607-551X(09)70116-0","article-title":"In vitro activities of antibiotic combinations against clinical isolates of Pseudomonas aeruginosa","volume":"20","author":"Chen","year":"2004","journal-title":"Kaohsiung J Med Sci"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1179\/joc.2005.17.4.355","article-title":"In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa","volume":"17","author":"Piccoli","year":"2005","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B65","first-page":"106","article-title":"Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill","volume":"57","author":"Hosgor","year":"2008","journal-title":"West Indian Med J"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijantimicag.2011.01.028","article-title":"In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology","volume":"38","author":"Kresken","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B67","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3349\/ymj.2010.51.1.111","article-title":"In-vitro efficacy of synergistic antibiotic combinations in multidrug resistant Pseudomonas aeruginosa strains","volume":"51","author":"Dundar","year":"2010","journal-title":"Yonsei Med J"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B68","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9343(86)90490-0","article-title":"Aminoglycosides plus \u03b2-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions","volume":"80","author":"Giamarellou","year":"1986","journal-title":"Am J Med"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000222001","article-title":"Antibacterial activity of ticarcillin, tobramycin and gentamicin alone and in combination against Pseudomonas aeruginosa in vitro","volume":"23","author":"Ullmann","year":"1977","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B70","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/AAC.30.1.25","article-title":"In vitro activity of piperacillin, ticarcillin, and mezlocillin alone and in combination with aminoglycosides against Pseudomonas aeruginosa","volume":"30","author":"Lyon","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B71","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jac\/46.6.901","article-title":"Combined effects of meropenem and aminoglycosides on Pseudomonas aeruginosa in vitro","volume":"46","author":"Nakamura","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B72","doi-asserted-by":"crossref","first-page":"e28177","DOI":"10.1371\/journal.pone.0028177","article-title":"Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B","volume":"6","author":"Lim","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B73","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0924-8579(02)00269-8","article-title":"In vitro activity of \u03b2-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa","volume":"21","author":"Song","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B74","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1128\/AAC.01434-10","article-title":"In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides","volume":"55","author":"Jassem","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B75","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fmicb.2016.01223","article-title":"Berberine is a novel type efflux inhibitor which attenuates the MexXY-mediated aminoglycoside resistance in Pseudomonas aeruginosa","volume":"7","author":"Morita","year":"2016","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B76","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1128\/AAC.01785-15","article-title":"Polymyxin susceptibility in Pseudomonas aeruginosa linked to the MexXY-OprM multidrug efflux system","volume":"59","author":"Poole","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/AAC.26.2.250","article-title":"Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa","volume":"26","author":"Bryan","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B78","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1128\/JB.164.3.1256-1261.1985","article-title":"Binding of polycationic antibiotics and polyamines to lipopolysaccharides of Pseudomonas aeruginosa","volume":"164","author":"Peterson","year":"1985","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B79","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1128\/AAC.29.3.496","article-title":"Interaction of polycationic antibiotics with Pseudomonas aeruginosa lipopolysaccharide and lipid A studied by using dansyl-polymyxin","volume":"29","author":"Moore","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B80","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.37.4.715","article-title":"Interaction of gentamicin with the A band and B band lipopolysaccharides of Pseudomonas aeruginosa and its possible lethal effect","volume":"37","author":"Kadurugamuwa","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B81","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000007199","article-title":"Ionic binding of 3H-gentamicin and short-time bactericidal activity of gentamicin against Pseudomonas aeruginosa isolates with different lipopolysaccharide structures","volume":"45","author":"Saika","year":"1999","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B82","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/BF01975036","article-title":"Antibiotic uptake into Gram-negative bacteria","volume":"7","author":"Hancock","year":"1988","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B83","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1126\/science.135.3508.1067","article-title":"Synergism between streptomycin and penicillin: a proposed mechanism","volume":"135","author":"Plotz","year":"1962","journal-title":"Science"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B84","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/AAC.31.1.108","article-title":"Early effects of \u03b2-lactams on aminoglycoside uptake, bactericidal rates, and turbidimetrically measured growth inhibition in Pseudomonas aeruginosa","volume":"31","author":"Miller","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B85","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1172\/JCI106758","article-title":"Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14C-labeled streptomycin by enterococci","volume":"50","author":"Moellering","year":"1971","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B86","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1128\/AAC.30.5.763","article-title":"Penicillin-induced effects on streptomycin uptake and early bactericidal activity differ in viridans group and enterococcal streptococci","volume":"30","author":"Miller","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1432-1033.1979.tb02031.x","article-title":"Comparative studies of penicillin-binding proteins in Pseudomonas aeruginosa and Escherichia coli","volume":"100","author":"Noguchi","year":"1979","journal-title":"Eur J Biochem"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B88","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.72.8.2999","article-title":"Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12","volume":"72","author":"Spratt","year":"1975","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B89","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1128\/JB.145.1.333-340.1981","article-title":"Evidence for involvement of penicillin-binding protein 3 in murein synthesis during septation but not during cell elongation","volume":"145","author":"Botta","year":"1981","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B90","doi-asserted-by":"crossref","first-page":"e07118","DOI":"10.7554\/eLife.07118","article-title":"Coordination of peptidoglycan synthesis and outer membrane constriction during Escherichia coli cell division","volume":"4","author":"Gray","year":"2015","journal-title":"eLife"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B91","volume-title":"Short Protocols in Molecular Biology","author":"Ausubel","year":"1992","edition":"2nd edn."},{"key":"key\n\t\t\t\t20180626060813_dkx539-B92","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/nbt1183-784","article-title":"A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in Gram-negative bacteria","volume":"1","author":"Simon","year":"1983","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B93","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.36.9.1847","article-title":"Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa","volume":"36","author":"Masuda","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180626060813_dkx539-B94","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-1119(98)00130-9","article-title":"A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants","volume":"212","author":"Hoang","year":"1998","journal-title":"Gene"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/5\/1247\/25088067\/dkx539.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T04:25:40Z","timestamp":1603599940000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/73\/5\/1247\/4840574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,6]]},"references-count":94,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,2,6]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx539","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,2,6]]}}}